Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt No Debt
MDXG's Cash to Debt is ranked higher than
88% of the 475 Companies
in the Global Medical Devices industry.

( Industry Median: 2.09 vs. MDXG: No Debt )
MDXG' s 10-Year Cash to Debt Range
Min: 0   Max: No Debt
Current: No Debt

Equity to Asset 0.84
MDXG's Equity to Asset is ranked higher than
87% of the 447 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. MDXG: 0.84 )
MDXG' s 10-Year Equity to Asset Range
Min: 0.44   Max: 0.89
Current: 0.84

0.44
0.89
F-Score: 8
Z-Score: 48.19
M-Score: -2.37
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating margin (%) 1.07
MDXG's Operating margin (%) is ranked higher than
68% of the 459 Companies
in the Global Medical Devices industry.

( Industry Median: 5.91 vs. MDXG: 1.07 )
MDXG' s 10-Year Operating margin (%) Range
Min: -1334.98   Max: -4.46
Current: 1.07

-1334.98
-4.46
Net-margin (%) 0.99
MDXG's Net-margin (%) is ranked higher than
68% of the 459 Companies
in the Global Medical Devices industry.

( Industry Median: 4.15 vs. MDXG: 0.99 )
MDXG' s 10-Year Net-margin (%) Range
Min: -1447.4   Max: -6.95
Current: 0.99

-1447.4
-6.95
ROE (%) 1.41
MDXG's ROE (%) is ranked higher than
68% of the 445 Companies
in the Global Medical Devices industry.

( Industry Median: 5.20 vs. MDXG: 1.41 )
MDXG' s 10-Year ROE (%) Range
Min: -276.61   Max: -8.79
Current: 1.41

-276.61
-8.79
ROA (%) 1.20
MDXG's ROA (%) is ranked higher than
70% of the 475 Companies
in the Global Medical Devices industry.

( Industry Median: 2.77 vs. MDXG: 1.20 )
MDXG' s 10-Year ROA (%) Range
Min: -557.14   Max: -6.86
Current: 1.2

-557.14
-6.86
ROC (Joel Greenblatt) (%) 5.57
MDXG's ROC (Joel Greenblatt) (%) is ranked higher than
72% of the 473 Companies
in the Global Medical Devices industry.

( Industry Median: 9.15 vs. MDXG: 5.57 )
MDXG' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -2458.54   Max: -22.82
Current: 5.57

-2458.54
-22.82
Revenue Growth (3Y)(%) 293.60
MDXG's Revenue Growth (3Y)(%) is ranked higher than
100% of the 341 Companies
in the Global Medical Devices industry.

( Industry Median: 5.00 vs. MDXG: 293.60 )
MDXG' s 10-Year Revenue Growth (3Y)(%) Range
Min: 0   Max: 293.6
Current: 293.6

0
293.6
EBITDA Growth (3Y)(%) -60.30
MDXG's EBITDA Growth (3Y)(%) is ranked higher than
52% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 1.60 vs. MDXG: -60.30 )
MDXG' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0   Max: 152
Current: -60.3

0
152
EPS Growth (3Y)(%) -40.50
MDXG's EPS Growth (3Y)(%) is ranked higher than
55% of the 298 Companies
in the Global Medical Devices industry.

( Industry Median: 3.60 vs. MDXG: -40.50 )
MDXG' s 10-Year EPS Growth (3Y)(%) Range
Min: -64   Max: 397.8
Current: -40.5

-64
397.8
» MDXG's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q4 2013

MDXG Guru Trades in Q4 2013

Caxton Associates 50,000 sh (New)
Steven Cohen 898,000 sh (New)
Jim Simons 100,350 sh (New)
» More
Q1 2014

MDXG Guru Trades in Q1 2014

Steven Cohen 1,035,000 sh (+15.26%)
Caxton Associates Sold Out
Jim Simons Sold Out
» More
Q2 2014

MDXG Guru Trades in Q2 2014

Jim Simons 179,900 sh (New)
Steven Cohen 906,800 sh (unchged)
» More
Q3 2014

MDXG Guru Trades in Q3 2014

Joel Greenblatt 17,878 sh (New)
Jim Simons 251,000 sh (+39.52%)
Steven Cohen 825,000 sh (-9.02%)
» More
» Details

Insider Trades

Latest Guru Trades with MDXG

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2014-09-30 New Buy$6.28 - $7.44 $ 11.8770%17878
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 1978.30
MDXG's P/E(ttm) is ranked higher than
70% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 85.90 vs. MDXG: 1978.30 )
MDXG' s 10-Year P/E(ttm) Range
Min: 1151.67   Max: 1978.33
Current: 1978.3

1151.67
1978.33
P/B 15.42
MDXG's P/B is ranked higher than
53% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 3.88 vs. MDXG: 15.42 )
MDXG' s 10-Year P/B Range
Min: 5.5   Max: 21.82
Current: 15.42

5.5
21.82
P/S 13.04
MDXG's P/S is ranked higher than
57% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 3.41 vs. MDXG: 13.04 )
MDXG' s 10-Year P/S Range
Min: 6.84   Max: 148
Current: 13.04

6.84
148
PFCF 237.40
MDXG's PFCF is ranked higher than
78% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. MDXG: 237.40 )
MDXG' s 10-Year PFCF Range
Min: 138.2   Max: 237.4
Current: 237.4

138.2
237.4
EV-to-EBIT 1179.58
MDXG's EV-to-EBIT is ranked higher than
68% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 64.69 vs. MDXG: 1179.58 )
MDXG' s 10-Year EV-to-EBIT Range
Min: -299.1   Max: 1247
Current: 1179.58

-299.1
1247
Current Ratio 5.35
MDXG's Current Ratio is ranked higher than
86% of the 467 Companies
in the Global Medical Devices industry.

( Industry Median: 2.79 vs. MDXG: 5.35 )
MDXG' s 10-Year Current Ratio Range
Min: 0.05   Max: 7.08
Current: 5.35

0.05
7.08
Quick Ratio 5.02
MDXG's Quick Ratio is ranked higher than
88% of the 467 Companies
in the Global Medical Devices industry.

( Industry Median: 2.01 vs. MDXG: 5.02 )
MDXG' s 10-Year Quick Ratio Range
Min: 0.05   Max: 6.7
Current: 5.02

0.05
6.7

Valuation & Return

vs
industry
vs
history
Price/Net Cash 39.57
MDXG's Price/Net Cash is ranked higher than
85% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. MDXG: 39.57 )
MDXG' s 10-Year Price/Net Cash Range
Min: 20.43   Max: 140
Current: 39.57

20.43
140
Price/Net Current Asset Value 24.73
MDXG's Price/Net Current Asset Value is ranked higher than
78% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. MDXG: 24.73 )
MDXG' s 10-Year Price/Net Current Asset Value Range
Min: 13.62   Max: 140
Current: 24.73

13.62
140
Price/Tangible Book 18.85
MDXG's Price/Tangible Book is ranked higher than
58% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 6.71 vs. MDXG: 18.85 )
MDXG' s 10-Year Price/Tangible Book Range
Min: 10.57   Max: 237.5
Current: 18.85

10.57
237.5
Price/DCF (Projected) 53.96
MDXG's Price/DCF (Projected) is ranked higher than
79% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. MDXG: 53.96 )
MDXG' s 10-Year Price/DCF (Projected) Range
Min: 33.64   Max: 354.5
Current: 53.96

33.64
354.5
Price/Median PS Value 1.04
MDXG's Price/Median PS Value is ranked higher than
81% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 1.20 vs. MDXG: 1.04 )
MDXG' s 10-Year Price/Median PS Value Range
Min: 0.59   Max: 11.25
Current: 1.04

0.59
11.25
Price/Graham Number 32.98
MDXG's Price/Graham Number is ranked higher than
72% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. MDXG: 32.98 )
MDXG' s 10-Year Price/Graham Number Range
Min: 20.56   Max: 20.56
Current: 32.98

Earnings Yield (Greenblatt) 0.10
MDXG's Earnings Yield (Greenblatt) is ranked higher than
66% of the 469 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. MDXG: 0.10 )
MDXG' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.1   Max: 0.1
Current: 0.1

Business Description

Industry: Medical Devices » Medical Devices
Compare: » details
Traded in other countries:MXE.Germany,
MiMedx Group, Inc. was incorporated in Florida on February 28, 2008. The Company develops clinical solutions for the use of its biomaterials to regenerate soft tissue in wound healing, orthopedics and other specialty fields of medicine. It is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products and allografts processed from human amniotic membrane. Its biomaterial platform technologies include the device technologies HydroFix and CollaFixM, and its tissue technologies, AmnioFix and EpiFix. It is a supplier of allografts processed from amniotic tissue, having supplied approximately over 200,000 allografts to date for application in the Surgical, Orthopedic, Spinal, Wound Care, Ophthalmic, and Dental segments of healthcare. Its technology and products are Purion, AmnioFix, EpiFix and other Tissue -Based Allografts and Medical Devices- CollaFix and HydroFix. The Company operates a licensed tissue bank. Its solutions are being used to treat chronic wounds, including diabetic foot ulcers, venous stasis ulcers, arterial ulcers and pressure ulcers, burns and surgical wounds.
» More Articles for MDXG

Headlines

Articles On GuruFocus.com
No related article found.

More From Our Partners
Bull of the Day: MiMedx (MDXG) - Bull of the Day Dec 12 2014 - ZACKS

More From Other Websites
MiMedx Raises Expectations For 2015 Revenue To Range From $175 Million To $190 Million Dec 15 2014
Bull of the Day: MiMedx (MDXG) Dec 12 2014
MiMedx To Present At The Oppenheimer 25th Annual Healthcare Conference Dec 04 2014
Can MiMedx Group (MDXG) Run Higher on Strong Earnings Estimate Revisions? Nov 25 2014
MIMEDX GROUP, INC. Financials Nov 19 2014
Thirteen Poster Abstracts Chronicling The Clinical Use, Cost Effectiveness And Accelerated Healing... Nov 18 2014
Multi-Center Comparative Study Of MiMedx EpiFix® And Organogenesis Apligraf® Determines EpiFix Has... Nov 17 2014
10-Q for MiMedx Group, Inc. Nov 12 2014
MIMEDX GROUP, INC. Files SEC form 10-Q, Quarterly Report Nov 10 2014
MiMedx® Adds New Executive Nov 07 2014
MiMedx® Adds New Executive Nov 07 2014
MiMedx To Present At Two Healthcare Conferences Nov 05 2014
MiMedx To Present At Two Healthcare Conferences Nov 05 2014
MiMedx posts 3Q profit Oct 30 2014
MiMedx posts 3Q profit Oct 30 2014
MiMedx Group Inc Earnings Call scheduled for 10:30 am ET today Oct 30 2014
MIMEDX GROUP, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Oct 30 2014
MiMedx Achieves Record Revenue And Records First Operating Profit Oct 30 2014
MiMedx Achieves Record Revenue And Records First Operating Profit Oct 30 2014
Q3 2014 MiMedx Group Inc Earnings Release - Before Market Open Oct 30 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK